公司資料

Genprex 股價、新聞與催化劑

股票代碼:: GNPX
交易所:: NASDAQ
產業:: Biopharma
所在地:: United States

股票表現

4.47 USD (+3.59%)

收盤價

最後更新: 2026年8月17日

7.78M USD

市值

股價為何變動

As of Aug 17, 2026, GNPX closed up 3.59% at $4.47. No new same-company headline was identified in the current news window.

公司概覽

業務概覽

Genprex is a gene-therapy and oncology company focused on cancer and diabetes-related programs. Its platform has long centered on genetic medicine in difficult disease settings.

所在地與產業分類

Headquartered in the United States and listed on NASDAQ, Genprex sits in specialty biotechnology.

商業模式特徵

The company depends on platform validation, clinical progress, and the ability to translate gene-delivery science into value.

生技產業定位

Genprex is a high-catalyst genetic-medicine name with strong dependence on early results.

未來催化劑

Genprex’s catalysts are the oncology and diabetes platforms, plus any strategic update that shows the company can still create value. The market needs a more convincing clinical path.